peripheral 🀦 πŸ‡©πŸ‡ͺ πŸ’° (@greentardscycle) header
peripheral 🀦 πŸ‡©πŸ‡ͺ πŸ’° (@greentardscycle) profile picture

Iβ€˜m stupid, Iβ€˜m German and I hate money

Joined December 2020
Play stupid games, win stupid prices Now pay the price, Germany for the fucking Greens you voted in, who subsequently closed our nuclear power plants
1
220
peripheral 🀦 πŸ‡©πŸ‡ͺ πŸ’° retweeted
The establishment of the Dubai Mercantile Exchange (DME) Oman Crude Oil Futures Contract (OQD) offers a clear historical blueprint for liquidity formation in greenfield physically delivered commodity contracts. When DME launched the Oman Crude futures contract, it filled a market structure gap: the Middle East lacked a transparent, physically deliverable benchmark for Middle East crude bound for Asia. *DME averaged 1,000–3,000 contracts per day (~1–3 million barrels per day) in its initial years. A key factor was the sovereign anchors & physical backing, The Oman Ministry of Oil & Gas switched its official selling price (OSP) to the DME Oman settlement price. This forced real physical barrels to clear through the contract, guaranteeing physical delivery interest. This had a critical physical follow through where Chinese, Japanese, and South Korean refiners needed exact Middle East medium-sour crude hedging so the had to have held positions into expiry for physical delivery, driving open interest rather than purely rolling positions. Finally the real boost came from established connectivity to distribution that did not need to be jumpstarted when CME Group got a equity stake in DME and provided access via CME Globex/ClearPort, immediately plugging the contract into international institutional order-routing systems. Just as DME needed the Omani government to anchor physical barrels, @abaxx_exchange requires major physical players like Zhonggong, Cheniere, Asian buyers of LNG or physical metals merchants to commit baseline commercial volume to the exchange.
1
1
2
19
7,638
Not all heros wear capes! Keeping my fingers crossed for you JJ
Yesterday November 16th was 11 years to the day that I walked into the cancer center for my very first round of chemo, I was only supposed to do 12 but for the last 11 years it's basically been nonstop I remember how scared I was of chemo I didn't know what to expect the
226
The urgent need to fuck up Europeβ€˜s pensions, too before this private clown-show finally goes to hell?!
177
Can GS move $NVDA onto its conviction buy list already, pls
β€œNVIDIA MUST DIE!” - Part Deux Thinking aloud on who stands to benefit the most from Jensen's possible downfall ( h/t @gave_vincent). Also, a history lesson for the kids who don't know the gentleman on the right. 🌳πŸ₯ΉπŸ™ shrubstack.com/p/nvidia-must…
1
1
190
My sonβ€˜s account performance Maybe he should start an overpriced s*bstack or a dischord channel?! πŸ˜‚
I let my 12 y/o pick stocks in her Greenlight account to get her interested in investing. She's recklessly overexposed to Hasbro, despite me warning her about the risks of being undiversified. She's up 46% YTD. I'll keep you all posted on her next buy.
1
292
If I got a dollar for each time someone claimed that MS Office is toast, Iβ€˜d be richer than Bill Gates and Iβ€˜m not even long $MSFT Let me file this under: shit you hear right before an Anthropic IPO
2
237
Looking around, Iβ€˜m less sure about mental illness
Anthropic CEO predicts cancer, Alzheimer's, heart disease, mental illness will be cured in less than 10 years ACCELERATE
1
1
4
574
Abaxx Announces Conclusion of Independent Investigation; Findings Refute Short-Seller Allegations $ABXX.TO
1
10
1
91
3,035
Time for @retard3dinvst0r to own financy Gabe one more time πŸ˜‚
1
8
253
peripheral 🀦 πŸ‡©πŸ‡ͺ πŸ’° retweeted
Imagine getting taken out by a single digit drawdown lol
Hearing Walleye, Samlyn, Engineers Gate, Lone Pine, many MLP pods, and many Verition pods are done. Check on your friends, it's a tough time out there
9
5
1
334
25,125
peripheral 🀦 πŸ‡©πŸ‡ͺ πŸ’° retweeted
Today, the @FDA granted Priority Review to @uniQure_NV AMT-130, bringing the first potential disease-modifying therapy for Huntington’s disease one step closer to patients. I learned this news while my father lay in the ICU, on a ventilator, with aspiration-related pneumonia. Pneumonia is the leading cause of death in Huntington’s disease. My father is now confronting one of the very complications that make this disease so devastating. That is what the irreversible cost of waiting looks like. A few years ago, he was still running the business he built over 30 years ago. An accomplished businessman, inventor, and published author. Today, Huntington’s disease has taken his independence, his ability to swallow, much of his ability to communicate, and now threatens his life. My grandmother was diagnosed with HD in 1999. She died in 2011. Twenty-seven years after her diagnosis, we still have no FDA-approved treatment that slows this devastating disease. As a little girl, I watched HD take my grandmother. Today, my daughter, named in her honor, is watching the same disease take her grandfather and great-aunt. I am profoundly grateful for today's milestone. But I cannot ignore the human cost of getting here. I welcome the FDA's decision to grant Priority Review to AMT-130 and strongly support its consideration under the Accelerated Approval pathway. Our community has contributed decades of natural-history research, patient-experience data, and evidence of our willingness to accept meaningful risk. Every day of delay carries consequences that no subsequent approval can undo. Years ago, my father asked me, β€œChristina, what are you doing to leave the world a better place?” Dad, this is my answer. I'm fighting for you, for our family, for the more than 41,000 Americans living with Huntington’s disease, and the 200,000+ at risk of inheriting it. I'm fighting for a future where my daughter never has to stand before the FDA, pleading for a treatment to save her mother, her brother, her aunts, or another generation of our family. I want her to inherit my grandmother's name. Not her fate. And certainly not this fight. πŸ’™πŸ’œ #HuntingtonsDisease #RareDisease #CureHD
12
23
10
189
13,538
Make sure the books can take some risk when those IPOs come to market Nice little rug pull
The biggest deleveraging event in more than 10 years
245
Iβ€˜m pretty Haypped
In the last couple of years, Nicotine pouch consumption has slowly started to take over from Snus consumption. Nicotine pouches began being sold outside Sweden in Norway, the UK, and the US. Unlike Snus, the EU has not formally banned nicotine pouches but leaves it up to the member states to regulate them - for now. The result is that nicotine pouches are one of the fastest-growing consumer goods categories of the current times. In today’s consumer recession, it is hard to find consumer goods with a tailwind. But nicotine pouches are one of the few products that fit that bill.
2
277
W00t!! Love to see it. The greatest gift of OSS is seeing stuff you wouldn't have even imagined coming back.
Replying to @abaxx_labs
@abaxx_labs Agents++ in the wild - music industry. β€œAgents get information about the music, but never the music. Each agent gets its own cryptographic identity and a credential from a human that expires and lists exactly what it can read.” Source: linkedin.com/posts/connor-pa…
5
50
1,093